TP53 and cancer: On the other hand, exposure of the cells to prilocaine led to increased expression level of caspase 3 and TP53 genes and decreased expression level of AFP, GOLM1, and VEGF genes, implying the cell damage and the effectiveness of the drug in inhibiting cancer cells.